Advisory Services Network’s Beam Therapeutics BEAM Stock Holding History

Advisory Services Network’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-173	Closed	-$4.12K	–	2407
2026 Q1	$4.12K	Buy	+173	New	+$4.8K	﹤0.01%	3931
2024 Q1	–	Sell	-476	Closed	-$13K	–	1677
2023 Q4	$13K	Buy	+476	New	+$11.8K	﹤0.01%	2744
2023 Q2	–	Sell	-130	Closed	-$3.98K	–	1662
2023 Q1	$3.98K	Hold	130	–	–	﹤0.01%	3226
2022 Q4	$5.08K	Buy	+130	New	+$5.82K	﹤0.01%	3123
2021 Q3	–	Sell	-75	Closed	-$10K	–	1573
2021 Q2	$10K	Buy	+75	New	+$5.98K	﹤0.01%	2779

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Advisory Services Network's BEAM Position: Q2 2026 in Review

Advisory Services Network sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 173 shares — an estimated $4.12K sold.

Advisory Services Network first reported a position in BEAM in Q2 2021 and held it in 5 quarters. The position peaked at $13K in Q4 2023. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Advisory Services Network reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 173 Beam Therapeutics shares in Q2 2026, an estimated $4.12K.
Advisory Services Network first reported a position in Beam Therapeutics in Q2 2021 and held it in 5 quarters.
Advisory Services Network's Beam Therapeutics position peaked at $13K in Q4 2023.
278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.